Clinical Trial Update: A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2, multi-center, non-controlled trial evaluating sorafenib as adjuvant therapy in advanced renal cell carcinoma is described, with the trial status list…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN